Back to Search Start Over

[Psychopharmacological treatments in childhood and adolescence].

Authors :
Libal G
Schmeck K
Source :
Therapeutische Umschau. Revue therapeutique [Ther Umsch] 2009 Jun; Vol. 66 (6), pp. 467-74.
Publication Year :
2009

Abstract

Compared to adults, the use of psychopharmacological substances in childhood and adolescence is significantly more controversial. Often sensation-seeking media reports on the negative effects of psychopharmacological treatments of children and adolescents intensify this controversy on a regular basis. In addition, even pharmacologically trained experts--though frequently without expertise in Child and Adolescent Psychiatry--question the seriousness and thus the demands for treatment of psychiatric disorders in childhood and adolescence. Considering this background evidence based treatment decisions in pediatric psychopharmacology are of utmost importance. Effective psychopharmacotherapy needs to be distinguished from ineffective treatments. The pros and cons of such evidence based treatment approaches ought to be weighted out carefully together with the patients and their families. The aim of this article is to provide a rational and concise foundation for the use of psychopharmacotherapy for clinicians treating children and adolescents as well as to point out the currently best evidence for psychopharmacological treatments of selected disorders in child and adolescent psychiatry.

Subjects

Subjects :
Adolescent
Anti-Anxiety Agents adverse effects
Anti-Anxiety Agents classification
Anti-Anxiety Agents therapeutic use
Antidepressive Agents, Second-Generation adverse effects
Antidepressive Agents, Second-Generation classification
Antidepressive Agents, Second-Generation therapeutic use
Antidepressive Agents, Tricyclic adverse effects
Antidepressive Agents, Tricyclic classification
Antidepressive Agents, Tricyclic therapeutic use
Antipsychotic Agents adverse effects
Antipsychotic Agents classification
Antipsychotic Agents therapeutic use
Anxiety Disorders classification
Anxiety Disorders diagnosis
Anxiety Disorders drug therapy
Anxiety Disorders psychology
Attention Deficit Disorder with Hyperactivity classification
Attention Deficit Disorder with Hyperactivity diagnosis
Attention Deficit Disorder with Hyperactivity drug therapy
Central Nervous System Stimulants adverse effects
Central Nervous System Stimulants classification
Central Nervous System Stimulants therapeutic use
Child
Depressive Disorder classification
Depressive Disorder diagnosis
Depressive Disorder drug therapy
Depressive Disorder psychology
Dose-Response Relationship, Drug
Drug Approval
Evidence-Based Medicine
Humans
Mental Disorders classification
Mental Disorders diagnosis
Mental Disorders psychology
Patient Education as Topic
Psychotropic Drugs adverse effects
Psychotropic Drugs classification
Randomized Controlled Trials as Topic
Risk Factors
Selective Serotonin Reuptake Inhibitors adverse effects
Selective Serotonin Reuptake Inhibitors classification
Selective Serotonin Reuptake Inhibitors therapeutic use
Mental Disorders drug therapy
Psychotropic Drugs therapeutic use

Details

Language :
German
ISSN :
0040-5930
Volume :
66
Issue :
6
Database :
MEDLINE
Journal :
Therapeutische Umschau. Revue therapeutique
Publication Type :
Academic Journal
Accession number :
19496043
Full Text :
https://doi.org/10.1024/0040-5930.66.6.467